OBJECTIVE: To evaluate clinical outcome of bone or osteoarticular allografts. METHODS: From September 1991 to November 1997, large bone or osteoarticular defects secondary to bone tumors resection in 36 patients and severe trauma in 2 patients were repaired by deep frozen or lyophilized allogeneic osteoarticular or diaphysis graft. RESULTS: No obvious immune rejection to the grafts was observed in most of the patients in early stage after operation. The patients were followed up from 1 year and five months to 7 years and five months with an average of 4.2 years. Limb function was satisfactory in 74.19% of the 31 survival patients with large osteoarticular or diaphysis allografts. CONCLUSION: Cryopreserved or lyophilized allogeneic osteoarticular grafts with decreased antigenicity and good biocompatibility are suitable materials for repairing large bone or osteoarticular defects.
Objective To investigate the epidemiological characteristics of malignant tumor deaths in the registered population of Zhuhai city. Methods A retrospective survey of death from malignant tumor during 2004 and 2005 was performed in the registered population of Zhuhai city. This was based on the retrospective protocol of the third national survey of death cause. The mortality of main malignant tumor and cause of deaths were analyzed. Results During 2004 to 2005, the mean crude mortality and age-specific standardized mortality of malignant tumor were 90.3/100 000 and 97.2/100 000, respectively. Malignant tumor death was the most common cause of death in Zhuhai city, accounting for 21.8% of all deaths. The standardized mortalities in males and females were 119.7/100,000 and 71.6/100,000, respectively. The standardized rate in the male population was significantly higher than that of the female population (u=10.3, Plt;0.01). The mortality of malignant tumor tended to increase with age. The top five causes of malignant tumor deaths were lung cancer, liver cancer, colorectal cancer, nasopharyngeal cancer and gastric cancer. Their standardized mortalities were 20.9, 18.0, 8.7, 8.2, 8.1/100,000, respectively. Conclusion The mortality of mal ignant tumors has showed an increasing trend in Zhuhai city, with the main tumors being lung cancer, liver cancer, colorectal cancer, nasopharyngeal cancer and gastric cancer. Malignant tumor has become a common and frequently-occurring disease with a major impact on the life and health of people in Zhuhai city.
ObjectivesTo analyze the average daily medical expenditures for primary liver cancer in China from 2002 to 2011.MethodsThis study employed retrospective survey on multiple centers from 12 provinces and cities in China from 2002 to 2011, based on the continuous data from the Cancer Screening Program in the Urban China Project. The average daily medical expenditures of primary liver cancer patients and influencing factors were analyzed.ResultsA total of 11 045 liver cancer patients from 12 provinces and cities were included, with an average age of 55 and an average duration of hospitalization of 16.76 days. The average daily medical expenditures of liver cancer patients during the 10 years was 1 251 yuan (95%CI 1 236 to 1 266). The average daily medical expenditures was significantly different in regions (1 356 yuan in the east region, 1 209 yuan in the middle region and 1 068 yuan in the west region), types of hospital (1 341 yuan in general hospitals, 1 213 yuan in specialized hospitals) and hospital levels (1 293 yuan in 3A grade hospital, 805 yuan in non-3A grade hospital) (P<0.05). The average daily medical expenditures were 1 253 yuan for stage Ⅰ, 1 169 yuan for stage Ⅱ, 1 167 yuan for stageⅢ and 1 092 yuan for stage Ⅳ (P<0.05). From 2002 to 2011, the average daily medical expenditures of hospitalization increased from 1 079 yuan (95%CI 1 021 to 1 136) to 1 549 yuan (95%CI 1 486 to 1 613), with an average growth rate of 3.69%. Since 2007, a continuous growth was observed. Subgroup analysis suggested there were obvious differences in growth patterns between different regions and hospitals, as well as differences between various treatments.ConclusionsThe average daily medical expenditures of liver cancer in China had been increasing from 2002 to 2011 and there were significant differences between various regions and hospital levels. Combined with data on the change of duration of hospitalization, it can provide reference for the economic evaluation of the nation’s prevention and treatment policies for liver cancer.